Agios Pharma (AGIO) PT Maintained at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Price: $33.77 -3.84%
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
Cantor Fitzgerald analyst Eric Schmidt maintained the price target on Agios Pharma (NASDAQ: AGIO) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hesai (2525:HK) (HSAI) PT Lowered to HK$24.20 at Macquarie
- Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
